Yu Y - Search Results

1

HERC3 promotes YAP/TAZ stability and tumorigenesis independently of its ubiquitin ligase activity.

Yuan B, Liu J, Shi A, Cao J, Yu Y, Zhu Y, Zhang C, Qiu Y, Luo H, Shi J, Cao X, Xu P, Shen L, Liang T, Zhao B, Feng XH. Yuan B, et al. Among authors: yu y. EMBO J. 2023 Feb 15;42(4):e111549. doi: 10.15252/embj.2022111549. Epub 2023 Jan 4. EMBO J. 2023. PMID: 36598329 Free PMC article.

2

SCP4 Promotes Gluconeogenesis Through FoxO1/3a Dephosphorylation.

Cao J, Yu Y, Zhang Z, Chen X, Hu Z, Tong Q, Chang J, Feng XH, Lin X. Cao J, et al. Among authors: yu y. Diabetes. 2018 Jan;67(1):46-57. doi: 10.2337/db17-0546. Epub 2017 Aug 29. Diabetes. 2018. PMID: 28851713 Free PMC article.

3

Smad7 enables STAT3 activation and promotes pluripotency independent of TGF-β signaling.

Yu Y, Gu S, Li W, Sun C, Chen F, Xiao M, Wang L, Xu D, Li Y, Ding C, Xia Z, Li Y, Ye S, Xu P, Zhao B, Qin J, Chen YG, Lin X, Feng XH. Yu Y, et al. Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10113-10118. doi: 10.1073/pnas.1705755114. Epub 2017 Sep 5. Proc Natl Acad Sci U S A. 2017. PMID: 28874583 Free PMC article.

4

ALK phosphorylates SMAD4 on tyrosine to disable TGF-β tumour suppressor functions.

Zhang Q, Xiao M, Gu S, Xu Y, Liu T, Li H, Yu Y, Qin L, Zhu Y, Chen F, Wang Y, Ding C, Wu H, Ji H, Chen Z, Zu Y, Malkoski S, Li Y, Liang T, Ji J, Qin J, Xu P, Zhao B, Shen L, Lin X, Feng XH. Zhang Q, et al. Among authors: yu y. Nat Cell Biol. 2019 Feb;21(2):179-189. doi: 10.1038/s41556-018-0264-3. Epub 2019 Jan 21. Nat Cell Biol. 2019. PMID: 30664791

5

PTPN3 acts as a tumor suppressor and boosts TGF-β signaling independent of its phosphatase activity.

Yuan B, Liu J, Cao J, Yu Y, Zhang H, Wang F, Zhu Y, Xiao M, Liu S, Ye Y, Ma L, Xu D, Xu N, Li Y, Zhao B, Xu P, Jin J, Xu J, Chen X, Shen L, Lin X, Feng XH. Yuan B, et al. Among authors: yu y. EMBO J. 2019 Jul 15;38(14):e99945. doi: 10.15252/embj.201899945. Epub 2019 Jun 14. EMBO J. 2019. PMID: 31304624 Free PMC article.

6

TGF-β signaling in cell fate control and cancer.

Yu Y, Feng XH. Yu Y, et al. Curr Opin Cell Biol. 2019 Dec;61:56-63. doi: 10.1016/j.ceb.2019.07.007. Epub 2019 Aug 2. Curr Opin Cell Biol. 2019. PMID: 31382143 Review.

7

Author Correction: ALK phosphorylates SMAD4 on tyrosine to disable TGF-β tumour suppressor functions.

Zhang Q, Xiao M, Gu S, Xu Y, Liu T, Li H, Yu Y, Qin L, Zhu Y, Chen F, Wang Y, Ding C, Wu H, Ji H, Chen Z, Zu Y, Malkoski S, Li Y, Liang T, Ji J, Qin J, Xu P, Zhao B, Shen L, Lin X, Feng XH. Zhang Q, et al. Among authors: yu y. Nat Cell Biol. 2021 Mar;23(3):293. doi: 10.1038/s41556-021-00638-5. Nat Cell Biol. 2021. PMID: 33531669 No abstract available.

8

ZNF451 stabilizes TWIST2 through SUMOylation and promotes epithelial-mesenchymal transition.

Zeng W, Gu S, Yu Y, Feng Y, Xiao M, Feng XH. Zeng W, et al. Among authors: yu y. Am J Cancer Res. 2021 Mar 1;11(3):898-915. eCollection 2021. Am J Cancer Res. 2021. PMID: 33791162 Free PMC article.

9

PRMT5 Enables Robust STAT3 Activation via Arginine Symmetric Dimethylation of SMAD7.

Cai C, Gu S, Yu Y, Zhu Y, Zhang H, Yuan B, Shen L, Yang B, Feng XH. Cai C, et al. Among authors: yu y. Adv Sci (Weinh). 2021 Feb 24;8(10):2003047. doi: 10.1002/advs.202003047. eCollection 2021 May. Adv Sci (Weinh). 2021. PMID: 34026434 Free PMC article.

10

Imatinib blocks tyrosine phosphorylation of Smad4 and restores TGF-β growth-suppressive signaling in BCR-ABL1-positive leukemia.

Wang L, Gu S, Chen F, Yu Y, Cao J, Li X, Gao C, Chen Y, Yuan S, Liu X, Qin J, Zhao B, Xu P, Liang T, Tong H, Lin X, Feng XH. Wang L, et al. Among authors: yu y. Signal Transduct Target Ther. 2023 Mar 24;8(1):120. doi: 10.1038/s41392-023-01327-5. Signal Transduct Target Ther. 2023. PMID: 36959211 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38,011 results

Search Page